Eloria review

Eloria is a useful comparison for readers who understand the ordinary renewal charge and prepaid cancellation calculation. Confirm the actual pharmacy, formulation and state access before paying; a low first month does not establish a low ongoing cost.

Eloria Health LLC operates the telehealth platform. Its disclosures attribute clinical services to Arora Health & Aesthetics LLC and similar affiliated professional entities, with the treating clinician responsible for prescribing. The terms also reference Bask Health Inc.’s platform. Those roles distinguish the technology business from the medical practice; they do not establish which clinician would treat a particular patient.

Eloria describes partner pharmacies in general terms but does not name the dispensing pharmacy in its public pharmacy FAQ. Request that name before ordering, together with the proposed preparation and the practice responsible for follow-up. A description of licensed partners is a provider assertion, not independent verification of credentials or a patient-specific assignment.

The main weight-care offer is compounded weekly injections. A separate semaglutide tablet listing has different prices and much less formulation detail. These are distinct purchase options, so the tablet offer should not inherit the injection description, ingredients or prepaid plans.

Patients provide health information for clinical review, and prescribing remains an individual decision. Eloria advertises guidance, side-effect support, human support available around the clock, virtual fitness access, a member community and provider-directed laboratory work when needed. The advertised bundle is useful context, but ask which services apply to your plan and what outside services can create separate charges.

Terms require adults eighteen or older to be physically located in an operating state. Medical and pharmacy licensure qualify availability, and a complete current treatment-state roster is not supplied. Confirm access where you will receive care. A universal clinical BMI rule and the exact circumstances requiring laboratory work remain unestablished.

Monthly plans have a package for the first month and each renewal. The three-month injection plan has one package containing three vials; six-month plans have two packages and annual plans four, generally spaced about two to three months apart. Annual packages three and four require an online check-in and clinician approval; other refills can also require review. Package counts are purchase and fulfillment details, not dosing instructions.

Shipping is advertised as free for each package. The shipping policy allows two to three business days for processing and an average four to twelve business days for shipping, with possible delays. That is a longer planning window than the program page’s short two-to-three-day process estimate. Ask when the pharmacy expects to prepare and dispatch your actual order rather than planning around a guaranteed arrival date.

Monthly injection plans distinguish the introductory supply from subsequent supplies. Semaglutide is $79 for the first month and then $299 per monthly supply. Tirzepatide is $129 initially and then $399 per monthly supply. Both renew automatically; the introductory figures are not permanent monthly rates.

The full prepaid injection charges are $597 for three months, $1,074 for six months or $1,788 for twelve months of semaglutide. Tirzepatide totals are $837, $1,554 and $2,748 for those respective periods. Each prepaid plan automatically renews for its same full charge at the end of its period unless canceled. Dividing these totals into monthly equivalents does not create a month-to-month payment option.

Semaglutide tablets are listed separately at $249 for the first monthly supply, then $299 per monthly supply with automatic renewal. A prepaid tablet offer is not established. Confirm the actual preparation and availability before treating this as an alternative to the injections.

The advertised cash-pay bundle includes prescribed medication, clinical review and shipping, alongside the described support services. The terms allow separate charges for services outside the bundle. Insurance is not required, and HSA/FSA reimbursement depends on the member’s plan. Obtain an itemized charge for the chosen treatment rather than assuming every outside expense is covered.

Initial checkout places a card authorization; the refund policy says payment is captured only after provider approval. A denial releases the hold or refunds a captured charge. Renewals require an active prescription, with an unapproved renewal uncharged or refunded. The terms promise at least thirty days’ email notice of price changes.

To stop the next charge, the detailed cancellation policy requires a request to the published support email from the account email, using the subject “Cancel my plan,” at least forty-eight hours before billing. It states no cancellation fee. Portal auto-bill settings are also described, but a settings change alone is not established as satisfying that notice rule. Obtain confirmation that future billing has stopped.

Prescription orders can receive a full refund before transmission to the pharmacy. After transmission or shipment, they generally cannot be refunded, subject to exceptions for wrong, damaged or missing medication, confirmed filling errors or billing errors. Approved refunds are described as returning to the original card within five to ten business days. An unshipped order can already be past the general refund cutoff.

Voluntarily ending prepaid treatment has a separate calculation once a package has gone to the pharmacy: the refund is the amount paid minus $597 for each semaglutide package already sent, or $837 for each tirzepatide package. The result cannot fall below zero, and no additional balance is owed. For example, one package on the $1,074 six-month semaglutide plan leaves $477 refundable. This repricing matters even though the policy describes no cancellation fee.

Stopping renewal while continuing prepaid shipments does not trigger that repricing. If the clinician stops or does not renew treatment, or the pharmacy cannot fill it, unsent packages are refunded proportionally at the original plan rate. Eloria also advertises a conditional six-month weight-loss warranty, but complete eligibility and claim rules are not established. Do not budget around a guaranteed outcome or warranty payment.

Eloria describes weekly compounded semaglutide and tirzepatide injections, with B3, B6, B12 or glycine additions when clinically appropriate. Its semaglutide description specifies the base form rather than sodium or acetate salts. The exact concentration, ingredient combination and supplied quantity still depend on the prescription and pharmacy.

Compounded medicines are not FDA approved. Neither a pharmacy partnership nor a testing claim establishes equivalence to an approved branded drug or suitability for an individual. Confirm the proposed preparation, storage and follow-up with the treating clinician and dispenser. The separate semaglutide tablet listing does not establish its ingredients or exact preparation, and should not be assumed to match an approved oral product.